Navigation Links
IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts
Date:8/4/2008

Featuring Four Keynote Presentations, Four Pre-Conference Summits, Six Therapeutics Conference Topics, Three Post-Conference Workshops and Over

One Hundred and Seventy Exhibitors

WESTBOROUGH, Mass., Aug. 4 /PRNewswire/ -- Today IBC Life Sciences kicks off the 13th Annual Drug Discovery & Development of Innovative Therapeutics (DDT) World Congress in Boston, Massachusetts. 3,000 pharmaceutical, biotechnology, government and academic researchers, executives and technology providers to attend.

The keynote speakers include Elliott Sigal, M.D., Ph.D, from Bristol-Myers Squibb Company and William C. Bertrand, Jr., J.D. Executive Vice President, from MedImmune, Inc. Keynote panel discussions will approach "controversial" topics such as the FDA position on biomarkers and the impact of the 2008 elections on the future of the pharmaceutical/healthcare industry.

The conference sessions will cover six therapeutics areas and four additional drug discovery and development areas: Therapeutic Advances in: Cancer, Cardio-Metabolic, Neurodegeneration, Anti-infectives, Orphan Diseases, Inflammation; Transforming Technologies; Translational Medicine; Next Generation Therapeutics; and R&D Strategies.

The exhibit hall is open on Tuesday, August 5 (10:00 am -7:30 pm) and Wednesday, Aug 6 (10:30 am -5:00 pm). Over 170 drug discovery and development companies will be exhibiting, including 34 new exhibitors and 47 new product launches. Key sponsors of the event include Bend Research Inc., BMG LABTECH, CambridgeSoft Corporation, ChemAxon, ForteBio, Merck, and Tata Consultancy Services.

For additional details visit http://www.drugdisc.com.

About IBC Life Sciences

IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs, IBC actively researches the advancements
'/>"/>

SOURCE IBC Life Sciences
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
6. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
7. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
10. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
11. The Pittsburgh Life Sciences Greenhouse Adds New Companies to its Investment Portfolio

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ment grew by 29,000 jobs in October, and the fiel...uring the U.S. recession. However, clinics and spe...tems are coming closer to having to actually cut m... , (Vocus) November 24, 20...October despite the shedding of jobs in most other...
(Date:11/24/2009)...swire-Asia/ -- Shanghai Biolaxy announced the,Chin...s approved the,investigational new drug applicatio...innovative insulin formulation to treat diabetes. ...irst phase I clinical study. , Diabetes i...and poor,metabolism. The complications of diabetes...
(Date:11/24/2009)... Nov. 24 /PRNewswire-FirstCall/ - Hamilton Thorne ...a leading provider of advanced laser systems and i...y clinic markets, today reported operational and f...mber 30, 2009. , , Q3 2009 Highlights, - ...lion in Q3 2008, - Gross profit margin was 66...
(Date:11/24/2009)... Health Robotics today announced,th... a group of selected,investors. This recently form...me Health Robotics Canada, Inc. and will market, i...the Future concept, which includes the,revolutiona..., and OMM(TM).,Health Robotics Canada Inc. will al...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3
... to 2008 Lineup; Looks to Build Upon 2007 ... Dec. 20 Underscoring its continued commitment,to...reast cancer, the Avon,Foundation today announced ... the first time in Avon Walk history, the series w...ild upon the momentum of a record-breaking,2007 Av...
...ites Recently Initiated To Support Ongoing ...Expected in 2008 from Seven Ongoing or Planned Cli...ajor Disease Indications-, -Revenues Plus Cash On... Advance Programs as Planned-,...ls, Inc. (Nasdaq: PPHM ), a clinical stage biopha...
...nces for Potential Co-Development Opportunity in ...OUTH SAN FRANCISCO, Calif., Dec. 20 ,Exelixis, Inc...mitted a,comprehensive data report for IND candida...istol- Myers Squibb Company now has until the end ...e if it will select the compound for,further devel...
Other Biology Technology:Avon Foundation Announces 2008 Avon Walk for Breast Cancer Schedule 2Avon Foundation Announces 2008 Avon Walk for Breast Cancer Schedule 3Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 2Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 3Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 4Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008 5Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb 2Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb 3Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb 4
(Date:11/24/2009)...y named 12 new grant recipients for 2009. The awar...rk across a broad spectrum of lupus research. All ...otential to drive scientific discovery to ultimate... systemic lupus. , The 2009 grants go to both ne...ion and include interdisciplinary and highly promi...
(Date:11/24/2009)...dical Toxicology (ACMT) have signed an agreement t...f Medical Toxicology (JMT), the official journal ...iously published by the University of Pennsylvania...an international, peer-reviewed journal, is dedica...al toxicology. The quarterly journal focuses on t...
(Date:11/24/2009).... , The presence of increased body fat, and ... in the blood, hinders the loss and maintenance of...e University of Navarra conducted by Estbaliz Goye.... , The project, entitled "A nutrigenetic and nu...y weight and inflammation," examines how the indiv...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2AMERIGROUP Foundation Honors Warehouse of Hope Founder Craig Parson as a Healthy Hero 53505 1AMERIGROUP Foundation Honors Warehouse of Hope Founder Craig Parson as a Healthy Hero 53505 2New Study Shows That Pharmacogenomics Could Benefit Patients Spur Investment in Innovation 53501 1New Study Shows That Pharmacogenomics Could Benefit Patients Spur Investment in Innovation 53501 2New Study Shows That Pharmacogenomics Could Benefit Patients Spur Investment in Innovation 53501 3New Analysis 3A Women of Low Socio Economic Status Face Unique Challenges Related to Smoking Smoking Ban Policies 53498 1New Analysis 3A Women of Low Socio Economic Status Face Unique Challenges Related to Smoking Smoking Ban Policies 53498 2New Analysis 3A Women of Low Socio Economic Status Face Unique Challenges Related to Smoking Smoking Ban Policies 53498 3New Analysis 3A Women of Low Socio Economic Status Face Unique Challenges Related to Smoking Smoking Ban Policies 53498 4New Analysis 3A Women of Low Socio Economic Status Face Unique Challenges Related to Smoking Smoking Ban Policies 53498 5
...g Quarterly Review of Biology, biologists from Bin...stinct types of laughter ?laughter which is stimul... strategic. , "Laughter that occurs during everyd...s and humorless conversation is now being studied,...he unstated issue is whether such laughter is simi...
...tudy in Science , More than 100 scientists from A...g the genome of the mouse in a joint study lasting... completely overturned geneticists, traditional as...igious journal Science on 2nd September. The gener...ammals is much more complex than was hitherto supp...
...oration Ecology finds that in coastal Louisiana, o...re self-sustaining, and are additionally attractiv...ntial for long-term growth, and contribute to over...ae move in groups and water-borne chemicals stimul...ble to maintain themselves as new recruits settle ...
Other Biology News:Mouse genome much more complex than expected 2
Rabbit Anti-OCT6 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human ABCD4 Polyclonal Antibody, Unconjugated from Atlas Antibodies
... Oligonucleotide) Genome Set and MEEBO (Mouse Exon...tain a collection of open source oligo probes, lar...allowing interrogation of thousands of genes. Deve... Stanford University and UCSF, the sets enable the...
Rabbit Anti-Human XPC Polyclonal Antibody, Unconjugated from Abcam
Biology Products: